Search Results - "Jonsson, Elin"

  • Showing 1 - 20 results of 20
Refine Results
  1. 1

    Struggles for Regulatory Hardening: Exploring Swedish Politics on Corporate Social Responsibility by Jönsson, Elin

    Published in British journal of criminology (17-08-2023)
    “…Abstract In recent years, the idea of Corporate Social Responsibility (CSR) has undergone a shift towards hardening, illustrated by a wave of new mandatory and…”
    Get full text
    Journal Article
  2. 2

    Navigating Contradictory Demands: An Analysis of Corporate Responses to Regulatory Hardening by Jönsson, Elin

    Published in Critical criminology (Richmond, B.C.) (06-10-2024)
    “…Abstract Mandatory due diligence has become increasingly common to address the harmful impacts of corporations, forcing them to navigate hardened regulatory…”
    Get full text
    Journal Article
  3. 3

    Risky business: corporate risk regulation when managing allegations of crime by Jönsson, Elin

    Published in Crime, law, and social change (01-06-2019)
    “…This article seeks to develop an understanding of how corporations manage their social and ethical responsibilities, whilst simultaneously facing allegations…”
    Get full text
    Journal Article
  4. 4

    A Phase I Study of CHS 828 in Patients with Solid Tumor Malignancy by HOVSTADIUS, Peter, LARSSON, Rolf, JONSSON, Elin, SKOV, Torsten, KISSMEYER, Anne-Marie, KRASILNIKOFF, Klaus, BERGH, Jonas, KARLSSON, Mats O, LÖNNEBO, Anna, AHLGREN, Johan

    Published in Clinical cancer research (01-09-2002)
    “…CHS 828 is a cyanoguanidine, which has demonstrated potent antitumor activity in preclinical tumor models. The activity of CHS 828 in vitro showed only low to…”
    Get full text
    Journal Article
  5. 5

    Model for time dependency of cytotoxic effect of CHS 828 in vitro suggests two different mechanisms of action by Hassan, S B, Jonsson, E, Larsson, R, Karlsson, M O

    “…CHS 828 is a novel drug belonging to the cyanoguanidines. It has shown promising anticancer activity in many preclinical systems and is currently in early…”
    Get more information
    Journal Article
  6. 6
  7. 7

    Different beef breed sires used for crossbreeding with Swedish dairy cows - effects on calving performance and carcass traits by Eriksson, Susanne, Ask-Gullstrand, Patricia, Fikse, W. Freddy, Jonsson, Elin, Eriksson, Jan-Åke, Stålhammar, Hans, Wallenbeck, Anna, Hessle, Anna

    Published in Livestock science (01-02-2020)
    “…•Field data for different beef x dairy breed crosses and dairy breeds were analyzed.•Beef x dairy crossbreds were superior to dairy breeds for carcass…”
    Get full text
    Journal Article
  8. 8

    Anti-tobacco policy in schools: upcoming preventive strategy or prevention myth? A review of 31 studies by Galanti, Maria Rosaria, Coppo, Alessandro, Jonsson, Elin, Bremberg, Sven, Faggiano, Fabrizio

    Published in Tobacco Control (01-07-2014)
    “…Objective To summarise the evidence on effectiveness of school anti-tobacco policies (exposure) in preventing tobacco use (outcome) among high school students…”
    Get full text
    Journal Article Book Review
  9. 9

    Justice from Below: Struggles Against Corporate Misconduct in the National Contact Point System by Jönsson, Elin

    Published in Nordic journal of criminology (12-08-2024)
    “…For victims of corporate harm, accessing justice in the global landscape is fraught with challenges and limitations – but also contestation and conflict. This…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Compliance with guidelines for postoperative pain management in infants and children by Dürango, Sofie, Åkeson, Pia Karlsland, Jonsson, Elin, Nilsson, Eva, Åkeson, Jonas

    “…Background: Postoperative pain is still often being inadequately assessed and/or recorded in infants and young children despite evidence-based guidelines…”
    Get full text
    Journal Article
  12. 12

    CHS 828, a novel pyridyl cyanoguanidine with potent antitumor activity in vitro and in vivo by HJARNAA, P.-J. V, JONSSON, E, LATINI, S, DHAR, S, LARSSON, R, BRAMM, E, SKOV, T, BINDERUP, L

    Published in Cancer research (Chicago, Ill.) (15-11-1999)
    “…A new class of recently discovered antineoplastic agents, the pyridyl cyanoguanidines, exert a potent antitumor activity in rodents after oral administration…”
    Get full text
    Journal Article
  13. 13

    CHS 828 inhibits neuroblastoma growth in mice alone and in combination with antiangiogenic drugs by SVENSSON, Asa, BÄCKMAN, Ulrika, JONSSON, Elin, LARSSON, Rolf, CHRISTOFFERSON, Rolf

    Published in Pediatric research (01-05-2002)
    “…CHS 828 is a new chemotherapeutic drug, a pyridyl cyanoguanidine. CHS 828 has low toxicity and lacks known patterns of multidrug resistance. Here we report…”
    Get full text
    Journal Article
  14. 14

    Education Aid & National Interest : a Study of British and American National Security and Education Aid Strategies, 2010-2015 by Jonsson, May Elin

    Published 01-01-2020
    “…The adaptation of the Millennium Development Goals and Education for All targets in 2000 highlighted the importance of education in development efforts…”
    Get full text
    Dissertation
  15. 15
  16. 16

    In vitro evaluation of the efficacy of idarubicin in human tumour cells from patients with low‐grade non‐Hodgkin's lymphoma by Åleskog, Anna, Jonsson, Elin, Larsson, Rolf, Nygren, Peter, Kristensen, Jörgen, Sundström, Christer, Höglund, Martin

    Published in British journal of haematology (01-06-2002)
    “…Evaluating the potential benefit of the new anthracycline, idarubicin (Ida), in lymphoma, 58 tumour samples from patients suffering from low‐grade…”
    Get full text
    Journal Article
  17. 17

    In vivo activity of CHS 828 on hollow-fibre cultures of primary human tumour cells from patients by JONSSON, Elin, FRIBERG, Lena E, KARLSSON, Mats O, HASSAN, Saadia B, NYGREN, Peter, KRISTENSEN, Jörgen, THOLANDER, Bengt, BINDERUP, Lise, LARSSON, Rolf

    Published in Cancer letters (26-01-2001)
    “…Fresh human tumour cells from patients with ovarian cancer and chronic lymphocytic leukaemia were cultured in semipermeable hollow fibres. The fibres were…”
    Get full text
    Journal Article
  18. 18

    Activity of CHS 828 in primary cultures of human hematological and solid tumors in vitro by Åleskog, Anna, Bashir-Hassan, Saadia, Hovstadius, Peter, Kristensen, Jörgen, Höglund, Martin, Tholander, Bengt, Binderup, Lise, Larsson, Rolf, Jonsson, Elin

    Published in Anti-cancer drugs (01-11-2001)
    “…CHS 828 is a pyridyl cyanoguanidine that has shown promising preclinical anticancer activity against various experimental tumor models and is presently being…”
    Get full text
    Journal Article
  19. 19

    Determination of drug effect on tumour cells, host animal toxicity and drug pharmacokinetics in a hollow-fibre model in rats by JONSSON, Elin, FRIBERG, Lena E, KARLSSON, Mats O, SAADIA BASHIR HASSAN, FREIJS, Agneta, HANSEN, Klaus, LARSSON, Rolf

    “…Based on the previously published hollow-fibre assay mainly used for early in vivo anticancer drug screening, we wanted to develop an extended hollow-fibre…”
    Get full text
    Journal Article
  20. 20

    A hollow fiber model for in vitro studies of cytotoxic compounds: activity of the cyanoguanidine CHS 828 by Hassan, Saadia B, de la Torre, Manuel, Nygren, Peter, Karlsson, Mats O, Larsson, Rolf, Jonsson, Elin

    Published in Anti-cancer drugs (01-01-2001)
    “…The hollow fiber assay is currently used as an in vivo model for anticancer drug screening in nude mice, but it can also be used as an in vitro model. In the…”
    Get full text
    Journal Article